Pacer BioThreat Strategy ETF
VIRS
Chicago Board Options Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Pacer BioThreat Strategy ETF (VIRS) is an exchange-traded fund that tracks the LifeSci BioThreat Strategy Index, providing exposure to U.S.-listed companies whose products and services address biological threats to human health through seven key themes: research of current and future pandemics; combating agents of biological warfare; detecting the presence of biological threats; securing national borders, ports, and strengthening homeland security; aiding in stockpiling products needed during natural disasters and disease outbreaks; improving food and water safety and purity; and enabling technology to support work and stay-at-home mandates. The ETF invests in a market-cap weighted portfolio of equities in sectors such as biotechnology, healthcare, industrials, and technology, targeting companies involved in biothreat mitigation and resilience strategies for institutional and retail investors seeking thematic exposure to bio-defense and pandemic preparedness. Launched on June 24, 2020, and headquartered in Malvern, Pennsylvania, under the management of Pacer Advisors, Inc., a provider of strategy-driven ETFs founded in 2015, VIRS operates primarily in the U.S. market with a focus on large- and mid-capitalization stocks. In September 2024, Pacer Advisors announced the closure and liquidation of the VIRS ETF, with portfolio liquidation beginning on or about September 27, 2024, cessation of new creation units after October 10, 2024, and final distributions to shareholders on or about the Liquidation Date of October 11, 2024, marking a significant operational wind-down due to strategic portfolio rationalization by the Pacer Funds Trust Board of Trustees. Trading in VIRS shares halted prior to market open on the Liquidation Date, with proceeds distributed pro rata to remaining shareholders as a taxable event, after which the fund terminated. This decision reflects Pacer Advisors' ongoing evolution of its ETF lineup, which includes other series like Pacer Cash Cows Index and Trendpilot ETFs, amid assets under management surpassing $25 billion as of mid-2023.